Post by Vetter Pharma

💡 Innovative functionality that elevates performance: V‑OVS® 𝘯𝘦𝘹𝘵 Our new Luer Lock syringe closure system V‑OVS® 𝘯𝘦𝘹𝘵 introduces a range of functional enhancements designed to strengthen both performance and usability in everyday handling. With multiple updates working together, the next generation of our syringe closure system brings meaningful advancements to the user experience and to product protection. Key functional improvements include:
 • An innovative locking mechanism that supports a more reliable syringe‑to‑needle connection.
 • A unique tamper‑evidence seal that contributes to maintaining product integrity.
 • Smaller plastic bridges that lower the opening force needed during preparation.
 • And more...
 With these advancements, V‑OVS® 𝘯𝘦𝘹𝘵 builds on more than 20 years of proven V‑OVS® system performance, bringing forward a more capable and user‑oriented closure design ahead of its planned commercial launch in 2027. 👉 Learn more about how V‑OVS® 𝘯𝘦𝘹𝘵 can bring added value to your injectable product. Link in the comments!

Video Content